Third Party Target definition

Third Party Target means a Target that is the subject of a license or similar grant of rights pursuant to an agreement between CRISPR or one of its Affiliates and a Third-Party; provided, that such Target was licensed in accordance with the procedures set forth in Section 3.7 of the Joint Venture Agreement. For the avoidance of doubt, Third-Party Targets include all Excluded Targets.
Sample 1Sample 2Sample 3
Third Party Target means a Target for which FivePrime has reserved the right for a Third Party to research, develop or commercialize including the following with respect to such Target: (a) a sequence variant thereof, (b) any Biologic that is or is a fragment of such Target or a fragment or sequence variant thereof, (c) any Biologic or Compound that modulates the activity of such Target or a fragment or sequence variant thereof, or (d) any nucleic acid encoding a molecule described in (a) – (c) or a fragment or variant of such nucleic acid. For the avoidance of doubt, all Third Party Targets existing at any given time will be included on the then-current Third Party Target List.
Sample 1Sample 2Sample 3
Third Party Target shall have the meaning set forth in Section 3.4.5.
Sample 1Sample 2

Examples of Third Party Target in a sentence

  • FivePrime shall maintain a current Third Party Target List and shall update GSK within *** days of making any changes to the Third Party Target List.

  • Nothing herein shall be construed as preventing FivePrime from having the right to designate such reverted Third Party Target as a Reserved Target if FivePrime offers GSK such Target as a Hit as set forth in the immediately preceding sentence, and such Hit becomes a Reverted Hit as set forth in this Agreement.

  • For clarity, a Target resulting from a Screening Assay shall not be deemed a Hit if it is a Reserved Target (subject to Section 3.4.1(d)(i)(6)) or a Third Party Target.

  • The relevant date for purposes of the Documentary Evidence shall be the date as of which Arvinas and Genentech have both submitted their respective lists to the Third Party Target Reviewer for the relevant nomination.

  • If the information in an Expansion Notice or Substitution Notice or in Arvinas’ list of then-Excluded Targets is insufficient for the Third Party Target Reviewer to determine under Section 2.10.2(c) whether the Proposed Target is or is not an Excluded Target, then Genentech and/or Arvinas shall provide the Third Party Target Reviewer with such additional information as requested by the Third Party Target Reviewer as reasonably necessary to make such determination, which may include amino acid sequences.

  • At any time during the Expansion/Substitution Period, Genentech may, by notifying the Third Party Target Reviewer in writing, nominate a Proposed Target as an additional Target (an “Expansion Notice”) or, as relevant, as a substitute Target for an Exclusive Target (a “Substitution Notice”), to be included as an Exclusive Target under this Agreement (an “Expansion Target” or “Substitute Target,” respectively).

  • Within [***] Business Days after the Effective Date, ImmunoGen shall notify Novartis in writing of the existence of any Third Party Target Specific Rights within the Licensed Patent Rights, and shall provide Novartis with a copy of the license agreement covering such Third Party Target Specific Rights.

  • The Third Party Target Reviewer shall promptly, but no later than [**] after receiving Arvinas’ list under Section 2.10.2(b), determine whether the Proposed Target is or is not an Excluded Target based on Arvinas’ list of then-Excluded Targets.

  • If the Third Party Target Reviewer determines that the Proposed Target was in fact an Excluded Target, notwithstanding Section 2.10.2(d), the Proposed Target shall, with retroactive effect, no longer be deemed as an “Expansion Target” or “Substitute Target,” as applicable, under this Agreement, and for clarity, no corresponding payment shall be due under Section 2.10.2(f).

  • Within [**] of sending the Mis-Determination Notice, Arvinas shall submit to the Third Party Target Reviewer documentary evidence that the relevant Proposed Target was an Excluded Target at the time of Arvinas’ receipt of the applicable notice from Genentech under Section 2.10.2(b) (“Documentary Evidence”).


More Definitions of Third Party Target

Third Party Target means, at a given point in time, any Target that EXS is unable to Research under this Agreement because [***].
Sample 1Sample 2
Third Party Target means a Target that is the subject of a license or similar grant of rights pursuant to an agreement between CRISPR or one of its Affiliates and a Third-Party; [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. provided, that such Target was licensed in accordance with the procedures set forth in Section 3.7 of the JV Agreement. For the avoidance of doubt, Third-Party Targets include all Excluded Targets. The following terms shall have the meanings defined in the Section or Schedule indicated. Unless otherwise noted, the indicated Section or Schedule refers to the appropriate Section or Schedule of this Agreement. Additional Information Section 2.4(a) Agreement First Paragraph Antitrust Approval Exhibit C Antitrust Authority Exhibit C Antitrust Condition Exhibit C Antitrust Filing Exhibit C Antitrust Law Exhibit C […***…] […***…] Bayer First Paragraph Buffer Period Section 2.4(a) CRISPR First Paragraph […***…] […***…] Company First Paragraph Company Organization Documents Section 3.2(b)(i) of the JV Agreement Effective Date First Paragraph Excluded Covered Targets Section 3.6(i) of the JV Agreement Exclusive Field Party Section 2.5(b) Excluded Target Section 3.7 of the JV Agreement Form License Agreement Section 2.4(a) Information Section 4.1 of the Intellectual Property Management Agreement Initial Budget Section 8.11(a) of the JV Agreement Initial Business Plan Section 3.2(b)(xii) of the JV Agreement Interests Section 3.3 of the JV Agreement JV Agreement First Paragraph […***…] […***…] Key Results Memo Section 2.4(a) Management Board Section 7.1 of the JV Agreement Objective Section 3.1 of the JV Agreement Offer Terms Section 2.4(a) Opt-In Closing Section 2.5(h) Opt-In Effective Date Section 2.6(a) Opt-In Field Section 2.6(a) Opt-In Package Section 2.4(a) Opt-In Package Delivery Date Section 2.4(a) Opt-In Transaction Section 2.5(h) Optionee; Optionees First Paragraph Permitted COC Transfer Section 11.3 of the JV Agreement Preliminary Offer Section 2.5(f) Primary Indication Field Section 2.5(c) Qualifying Offer Section 2.4(a) Resolution Period Section 5.1 Revised Offer Section 2.5(g) Rolling Budget Section 8.11(b) of the JV Agreement Rolling Business Plan Section 8.11(b) of the JV Agreement Term Section 3.1 Transaction Documents Section 3.2(b) of the JV Agreement Winning Offe...
Sample 1Sample 2
Third Party Target means a Target which is proprietary in whole or in part to a Third Party and to which SB has obtained from each such Third Party the right to use in the Research Program and that is provided by SB to CADUS for use in the Research Program pursuant to this Agreement. For the purposes of this Agreement, all Third Party Targets are deemed to be proprietary to a Third Party.
Sample 1Sample 2
Third Party Target means a Target that is the subject of a license or similar grant of rights pursuant to an agreement between CRISPR or one of its Affiliates and a Third-Party; provided, that such Target was licensed in accordance with the procedures set forth in Section 3.7 of the Joint Venture agreement. For the avoidance of doubt, Third-Party Targets include all Excluded Targets.
Sample 1

Related to Third Party Target

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Third Party Terms means, if any, the end user license agreement(s) or similar terms for the Third Party Software, as applicable and attached as Exhibit D.

  • Third Party Technology means all Intellectual Property and products owned by third parties and licensed pursuant to Third Party Licenses.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Third Party Licensor means the relevant licensor of any Third Party Data or any Third Party Trade Xxxx;

  • Licensed Compound means (a) 3,4-Diaminopyridine, the chemical structure of which is set forth on Exhibit B-2; and (b) any derivatives, isomers, metabolites, prodrugs, acid forms, base forms, salt forms, or modified versions of such compound in (a).

  • Third Party IP means the Intellectual Property Rights of any third party that is not a party to this Contract, and that is not a Subcontractor.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Program Patent Rights means all Patent Rights that claim or cover patentable Program Know-How, including any Program-Specific Patent Rights.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Third Party Product means a product (whether hardware, software or services) supplied to you by a third party;

  • Third Party IPR means any Intellectual Property Rights not belonging to either party to this Agreement but used by the Supplier in the creation of the Deliverables and/or in the course of or in connection with the Project.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Third Party License means licenses from third parties governing third party software embedded or used in the Trading Platform.

  • Third Party Terminating Carrier means a Telecommunications Carrier to which traffic is terminated when CLEC originates traffic that is sent through AT&T-TSP’s network, i.e., CLEC is using AT&T-TSP’s Transit Traffic Service.

  • Third Party IP Claim has the meaning given to it in clause E8.7 (Intellectual Property Rights).

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • ISIS means the department’s individualized services information system.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Licensed Patent Rights means:

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.